RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 147 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,379,993 | -22.8% | 583,642 | -25.9% | 0.28% | +6.0% |
| Q2 2019 | $17,321,000 | -19.7% | 787,300 | 0.0% | 0.27% | -19.8% |
| Q1 2019 | $21,580,000 | -13.5% | 787,300 | -15.2% | 0.33% | -27.7% |
| Q4 2018 | $24,958,000 | -17.8% | 928,500 | -10.8% | 0.46% | +26.2% |
| Q3 2018 | $30,376,000 | -52.9% | 1,041,353 | -49.6% | 0.37% | -52.5% |
| Q2 2018 | $64,552,000 | +11.8% | 2,065,000 | -28.8% | 0.77% | +7.5% |
| Q1 2018 | $57,736,000 | +32.7% | 2,901,295 | 0.0% | 0.72% | +30.2% |
| Q4 2017 | $43,519,000 | – | 2,901,295 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 909,258 | $11,875,000 | 2.75% |
| RA Capital Management | 4,871,067 | $63,616,000 | 0.88% |
| NEA Management Company, LLC | 4,912,306 | $64,155,000 | 0.76% |
| Samsara BioCapital, LLC | 300,293 | $3,922,000 | 0.62% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,989,625 | $25,985,000 | 0.51% |
| Baker Brothers Advisors | 3,863,239 | $50,454,000 | 0.22% |
| ACT CAPITAL MANAGEMENT, LLC | 31,000 | $405,000 | 0.21% |
| Rock Springs Capital Management LP | 612,180 | $7,995,000 | 0.17% |
| GILDER GAGNON HOWE & CO LLC | 1,496,424 | $19,543,000 | 0.10% |
| FEDERATED HERMES, INC. | 3,011,053 | $39,324,000 | 0.08% |